An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression. Lu XX, Yang WX, Pei YC, Luo H, et al. Cancer Res 2023 Apr 14:CAN-22-0536. doi: 10.1158/0008-5472.CAN-22-0536.

Read + Share

Amedeo Smart

Independent Medical Education

Lu XX, Yang WX, Pei YC, Luo H, et al. An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression. Cancer Res 2023 Apr 14:CAN-22-0536. doi: 10.1158/0008-5472.CAN-22-0536.
PMID: 37057875